These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34930454)

  • 1. Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study.
    Schramm S; Jokisch M; Jöckel KH; Herring A; Keyvani K
    Alzheimers Res Ther; 2021 Dec; 13(1):202. PubMed ID: 34930454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
    Krizanovic N; Jokisch M; Jöckel KH; Schmidt B; Stang A; Schramm S
    J Alzheimers Dis; 2024; 100(2):495-507. PubMed ID: 38995781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Kallikrein-8 and Non-Amnestic Mild Cognitive Impairment: An Exploratory Study.
    Schramm S; Krizanovic N; Roggenbuck U; Jöckel KH; Herring A; Keyvani K; Jokisch M
    J Alzheimers Dis Rep; 2023; 7(1):327-337. PubMed ID: 37220622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease.
    Teuber-Hanselmann S; Rekowski J; Vogelgsang J; von Arnim C; Reetz K; Stang A; Jöckel KH; Wiltfang J; Esselmann H; Otto M; Tumani H; Herring A; Keyvani K
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):40-48. PubMed ID: 31371645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of delayed recall as a predictor of amnestic mild cognitive impairment development in normal older adults: a 7-year of longitudinal cohort study in Shanghai.
    Bao X; Li W; Liu Y; Li X; Yue L; Xiao S
    BMC Psychiatry; 2023 Nov; 23(1):892. PubMed ID: 38031039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and mild cognitive impairment in the general population: results of the Heinz Nixdorf recall study.
    Dlugaj M; Winkler A; Dragano N; Moebus S; Jöckel KH; Erbel R; Weimar C;
    J Alzheimers Dis; 2015; 45(1):159-74. PubMed ID: 25471191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer's pathology in mice.
    Herring A; Kurapati NK; Krebs S; Grammon N; Scholz LM; Voss G; Miah MR; Budny V; Mairinger F; Haase K; Teuber-Hanselmann S; Dobersalske C; Schramm S; Jöckel KH; Münster Y; Keyvani K
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):611-624. PubMed ID: 33341972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    Loewenstein DA; Curiel Cid RE; Kitaigorodsky M; Ortega A; Hincapie D; Zheng DD; Amaya A; Gallardo L; Manso L; Sosa J; Crocco EA
    J Alzheimers Dis; 2022; 90(1):313-322. PubMed ID: 36155503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    Li W; Zhao Z; Liu M; Yan S; An Y; Qiao L; Wang G; Qi Z; Lu J
    J Alzheimers Dis; 2022; 85(3):1063-1075. PubMed ID: 34897092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    Marra C; Gainotti G; Fadda L; Perri R; Lacidogna G; Scaricamazza E; Piccininni C; Quaranta D
    J Alzheimers Dis; 2016; 50(1):61-70. PubMed ID: 26639965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.
    Matías-Guiu JA; Curiel RE; Rognoni T; Valles-Salgado M; Fernández-Matarrubia M; Hariramani R; Fernández-Castro A; Moreno-Ramos T; Loewenstein DA; Matías-Guiu J
    J Alzheimers Dis; 2017; 56(2):733-742. PubMed ID: 27983554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic potential of urinary monocyte chemoattractant protein-1 for Alzheimer's disease and amnestic mild cognitive impairment.
    Xu Y; Shen YY; Zhang XP; Gui L; Cai M; Peng GP; Pan XD; Zhang J; Gan D; Li B; Cheng HP; Deng J; Li WW; Zeng GH; Shi AY; Zhou ZH; Luo BY; Chen XC; Wang YJ
    Eur J Neurol; 2020 Aug; 27(8):1429-1435. PubMed ID: 32282975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population.
    Kara K; Mahabadi AA; Weimar C; Winkler A; Neumann T; Kälsch H; Dragano N; Moebus S; Erbel R; Jöckel KH; Jokisch M
    J Alzheimers Dis; 2017; 55(1):359-369. PubMed ID: 27636851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Animal Fluency Performance in Amnestic Mild Cognitive Impairment and Cognitively Unimpaired Older Adults.
    Sharma V; Malek-Ahmadi M
    Alzheimer Dis Assoc Disord; 2023 Jul-Sep 01; 37(3):259-264. PubMed ID: 37561948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.
    Stricker NH; Lundt ES; Albertson SM; Machulda MM; Pudumjee SB; Kremers WK; Jack CR; Knopman DS; Petersen RC; Mielke MM
    J Alzheimers Dis; 2020; 76(1):261-274. PubMed ID: 32538841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.